Tackling the increasing complexity of CF care
Open Access
- 3 September 2015
- journal article
- review article
- Published by Wiley in Pediatric Pulmonology
- Vol. 50 (S40) , S74-S79
Abstract
Summary: Health outcomes for individuals with cystic fibrosis (CF) have dramatically improved in parallel with better organization of clinical care systems, evolution of novel therapeutics, and improvements in diagnosis and screening for CF and CF‐related complications. In parallel with these advances has come an increasing complexity and burden of care, leading to challenges with adherence to treatment regimens. As novel therapeutics continue to be developed and introduced to the CF care regimen, there are clear opportunities to refine and personalize care. This can be done by adding comparative effectiveness research to the CF clinical research paradigm and integrating novel technologies in drug delivery and remote monitoring that can facilitate adherence but also reduce the burden of treatment while maintaining efficacy. This review highlights both the challenges of the increasingly complex treatment regimens in CF and the opportunities to advance care by addressing adherence, implementation science, comparative effectiveness, and integration of novel technologies in CF care. Pediatr Pulmonol. 2015; 50:S74–S79.Keywords
Funding Information
- National Institutes of Health (K23 HL105541)
- Cystic Fibrosis Foundation
This publication has 61 references indexed in Scilit:
- Longitudinal association between medication adherence and lung health in people with cystic fibrosisJournal of Cystic Fibrosis, 2011
- Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ TechnologyJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2011
- Adherence with tobramycin inhaled solution and health care utilizationBMC Pulmonary Medicine, 2011
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutationNew England Journal of Medicine, 2010
- Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation scienceImplementation Science, 2009
- Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic FibrosisChest, 2009
- Early anti-pseudomonal acquisition in young patients with cystic fibrosis: Rationale and design of the EPIC clinical trial and observational study,Contemporary Clinical Trials, 2009
- High treatment burden in adults with cystic fibrosis: Challenges to disease self-managementJournal of Cystic Fibrosis, 2009
- Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Evaluating the public health impact of health promotion interventions: the RE-AIM framework.American Journal of Public Health, 1999